CRISPR Therapeutics AG Annual Depreciation in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
CRISPR Therapeutics AG quarterly/annual Depreciation history and growth rate from 2014 to 2023.
  • CRISPR Therapeutics AG Depreciation for the quarter ending June 30, 2024 was $4.8M, a 4% decline year-over-year.
  • CRISPR Therapeutics AG Depreciation for the twelve months ending June 30, 2024 was $19.4M, a 6.73% decline year-over-year.
  • CRISPR Therapeutics AG annual Depreciation for 2023 was $19.8M, a 17.8% decline from 2022.
  • CRISPR Therapeutics AG annual Depreciation for 2022 was $24.1M, a 34.6% increase from 2021.
  • CRISPR Therapeutics AG annual Depreciation for 2021 was $17.9M, a 96.7% increase from 2020.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $19.8M -$4.3M -17.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-21
2022 $24.1M +$6.2M +34.6% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-21
2021 $17.9M +$8.8M +96.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-21
2020 $9.1M +$4.4M +93.6% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-21
2019 $4.7M +$1.2M +34.3% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-15
2018 $3.5M +$500K +16.7% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-16
2017 $3M +$2.1M +233% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-12
2016 $900K +$800K +800% Jan 1, 2016 Dec 31, 2016 10-K 2019-02-25
2015 $100K +$100K Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 $0 Jan 1, 2014 Dec 31, 2014 10-K 2017-03-10
* An asterisk sign (*) next to the value indicates that the value is likely invalid.